Utama › Diabetes › Texas › Houston
Kajian klinikal Diabetes di Houston, TX
16 kajian untuk Diabetes sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Mengambil pesertaFasa 3
- PlanIt Research, PLLC, Houston
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Mengambil pesertaFasa 3
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
Mengambil pesertaFasa awal 1
- The University of Texas M. D. Anderson Cancer Center, Houston
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Mengambil pesertaFasa 2/3
- Clinical Research Strategies, Houston
- DaVita Clinical Research, Houston
- Aqua Research Institute, Houston
- dan 4 lagi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Mengambil pesertaFasa 1/2
- Accurate Clinical Research, Inc, Humble · 17 mi jauh
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Mengambil pesertaFasa 2
- Baylor College of Medicine, Houston
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
Mengambil pesertaSukarelawan sihat dialu-alukan
- Children's Nutrition Research Center, Houston
CGM for Management of Type 2 Diabetes in Pregnancy
Mengambil peserta
- University of Texas Health Science Center at Houston, Houston
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Mengambil pesertaFasa 2
- Baylor College of Medicine (BCM), Houston
- The University of Texas Health Science Center at Houston, Houston
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Mengambil pesertaFasa 4
- University of Texas Health Science Center, Houston
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
Mengambil peserta
- Aqua Research Institute Llc, Houston
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Mengambil pesertaKajian pemerhatian
- Baylor College of Medicine, Houston
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Baylor College of Medicine, Houston
Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing
Mengambil pesertaFasa 4
- Axsendo Clinical Research, Houston
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
Mengambil pesertaFasa 3
- Mt. Olympus Medical Research, Houston
Rare and Atypical Diabetes Network
Mengambil pesertaKajian pemerhatian
- Baylor College of Medicine, Houston
Kajian Diabetes di bandar lain
- Boston, MA23 kajian
- New York City, NY17 kajian
- Chicago, IL15 kajian
- Durham, NC14 kajian
- Aurora, CO14 kajian
- Baltimore, MD13 kajian
- Philadelphia, PA12 kajian
- Los Angeles, CA10 kajian
- Washington, DC10 kajian
- San Diego, CA10 kajian
- Indianapolis, IN10 kajian
- Queens, NY9 kajian
Kajian lain di Houston
- Kanser Paru-paru Bukan Sel Kecil145 kajian
- Kanser Payudara126 kajian
- Kanser (semua jenis)121 kajian
- Kanser Metastatik104 kajian
- Kanser Kolorektal102 kajian
- Kanser Ovari89 kajian
- Leukemia Mieloid Akut85 kajian
- Kanser Paru-paru78 kajian
- Kanser Prostat76 kajian
- Kanser Endometrium68 kajian
- Kanser Pankreas61 kajian
- Melanoma59 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.